RoboDesign's CrystalMation Technology to Be Installed at Novartis Institutes for BioMedical Research in Basel, Switzerland

20-Apr-2004

Carlsbad, California. RoboDesign International, Inc., announced that the Novartis Institutes for BioMedical Research (NIBR) in Basel, Switzerland (Novartis AG), has selected CrystalMation(TM) as a platform for its protein crystal imaging and analysis. CrystalMation, a fully modular and automated protein crystallization system, includes equipment for liquid handling, low volume dispense, imaging, storage and analysis.

NIBR will be integrating RoboDesign's Minstrel III(TM) and RoboIncubator(TM) combinations, the core of the CrystalMation technology, at their Basel site beginning in June 2004. The Minstrel III, an ultra-high resolution imaging system, can quickly and consistently image hanging, sitting, or microbatch drops in any plate type. As with all of the CrystalMation components, the Minstrel III was designed to be expandable and modular, and can be expanded with a wide array of software tools and multiple RoboIncubators, a temperature controlled plate storage and retrieval system.

Robert L. Corey, president and CEO of RoboDesign stated, "NIBR needs a protein crystal imaging and analysis system that could meet their demanding requirements for performance and reliability. As with our continuing relationships with many of the world's leading pharmaceutical, biotech, and research organisations, NIBR's decision to implement our technology further validates CrystalMation as a leading protein crystallization platform. We are pleased and excited to be working with the research division of Novartis, a world leader in helping to improve patients lives and look forward to a long and successful relationship."

https://www.bionity.com/en/news/36781/robodesign-s-crystalmation-technology-to-be-installed-at-novartis-institutes-for-biomedical-research-in-basel-switzerland.html